Prosecution Insights
Last updated: October 02, 2026

Examiner: GREENE, CAROLYN LEE

Tech Center 1700 • Art Units: 1637 1656 1681 1699 1758

This examiner grants 65% of resolved cases

Performance Statistics

65.3%
Allow Rate
At TC average
258
Total Applications
+47.3%
Interview Lift
1225
Avg Prosecution Days
Based on 213 resolved cases, 2023–2026

Rejection Statute Breakdown

8.0%
§101 Eligibility
8.6%
§102 Novelty
36.8%
§103 Obviousness
40.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18680693 METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA Non-Final OA Natera, Inc.
18317484 COMPOSITIONS AND METHODS FOR IMMUNE REPERTOIRE MONITORING Final Rejection Life Technologies Corporation
18137956 Methods and Kits to Detect Viral Particle Heterogeneity Non-Final OA LIFE TECHNOLOGIES CORPORATION
17250408 COMPOSITIONS AND METHODS FOR IMMUNE REPERTOIRE SEQUENCING Non-Final OA Life Technologies Corporation
16497143 POLYNUCLEOTIDE ADAPTERS AND METHODS OF USE THEREOF Final Rejection LIFE TECHNOLOGIES CORPORATION
18444024 COMPOSITIONS, SYSTEMS AND METHODS FOR ENZYME OPTIMIZATION Non-Final OA 10x Genomics, Inc.
18744995 DETECTION OF COLON NEOPLASIA BY ANALYSIS OF METHYLATED DNA Non-Final OA Mayo Foundation for Medical Education and Research
18191818 MICROSCOPE-FREE IMAGING Non-Final OA President and Fellows of Harvard College
18507761 AMPLIFICATION OLIGONUCLEOTIDES Final Rejection Singular Genomics Systems, Inc.
18251596 METHODS FOR FULL-LENGTH REVERSE TRANSCRIPTION PCR OF LONG RNAs CONTAINING MODIFIED RIBONUCLEOSIDES USING A THERMOSTABLE REVERSE TRANSCRIPTASE Non-Final OA Northwestern University
18813886 COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS Non-Final OA Nautilus Subsidiary, Inc.
18817550 METHODS FOR ANALYZING CYTOSINE METHYLATION AND HYDROXYMETHYLATION Non-Final OA GUARDANT HEALTH, INC.
18649007 METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT WITH APPLICATIONS TO ERROR CORRECTED NUCLEIC ACID SEQUENCING Non-Final OA UNIVERSITY OF WASHINGTON
18292665 MULTIPLEXED IN SITU SIGNAL AMPLIFICATION WITH SPLINT LIGATION EXTENSION (SLX) PROBES Non-Final OA University of Washington
18236022 BIOMARKERS OF RISK FOR INFECTION Non-Final OA University of Chicago
18475498 IMMUME CELL COUNTING BASED ON IMMUNE REPERTOIRE SEQUENCING Non-Final OA Roche Sequencing Solutions, Inc.
18644807 DNA mapping and sequencing on linearized DNA molecules Non-Final OA Drexel University
16969164 ASSAY FOR DETECTION OF ANDROGEN RECEPTOR VARIANTS Final Rejection Cornell University
18307406 EX-SITU SEQUENCING OF RCA PRODUCT GENERATED IN-SITU Final Rejection Miltenyi Biotec B.V. & Co. KG
16757297 METHODS AND COMPOSITIONS FOR THE PURIFICATION OF UNBIASED RNA Non-Final OA ZYMO RESEARCH CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month